Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

The healthcare sector accounted for 17.6% of the US economy in 2023, up 17.4% from 2022. The two primary drivers of this rise are the expansion of private health insurance and Medicare.

Recent health news highlights various developments, including Trump's spending bill impacting insurance costs, a major acquisition in the bioscience sector, and GSK's efforts to expand RSV vaccine ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research operations, highlighting its operational efficiency even as it reported lower ...

Trends Shaping the Health Care Sector in 2025. In 2024, there was a sizable lag in healthcare stocks. It looks, though, that trend has changed. As of May 2025, the healthcare sector is one of the ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.

Tuesday Sector Leaders: Materials, Healthcare April 29, 2025 — 02:32 pm EDT Written by BNK Invest for BNK Invest -> ...

Shares of the Health Care Select Sector SPDR Fund XLV are trading lower by 8.6% to $132.86 over the past week as tariff announcements from President Donald Trump last week spooked investors and ...